The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) trial1 published in this issue of THE JOURNAL is the largest controlled trial of psychotherapy ever completed. In this study, the first multisite behavioral trial funded by the National Heart, Lung, and Blood Institute (NHLBI), the ENRICHD investigators enrolled 2481 post–myocardial infarction (MI) patients from 73 hospitals in 8 US cities in a 6-month course of weekly cognitive behavior therapy (CBT) vs usual care. Three quarters of the study patients had depression, with the remainder included because of low perceived social support (LPSS). The goal was to determine whether treating depression and LPSS would reduce mortality and recurrent infarction. The intervention produced small, statistically significant decreases in depression symptoms and small, significant increases in perceived support. These differences did not translate into any benefit in event-free survival during a mean follow-up of 29 months, so the study is a negative trial. However, much was learned over the course of the ENRICHD trial, and more will be learned as the investigators and others try to understand why results were not as expected. The study also demonstrates that psychologists, psychiatrists, and cardiologists can successfully collaborate to test complicated intervention protocols with large numbers of patients from multiple sites. For these reasons, the ENRICHD trial will remain a standard of comparison for many years.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Thank you for submitting a comment on this article. It will be reviewed by JAMA editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 48
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
The Rational Clinical Examination About 16% of general medical patients report that they have palpitations.1 Within...
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Need assistance?
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.